Kevin R. Loughlin

Brigham and Women's Hospital, Harvard University

Papers

Total Citations

H-Index

About

Kevin R. Loughlin is a distinguished urological surgeon and researcher whose work has significantly advanced the understanding and management of postoperative complications in urological pelvic surgery. His key research areas include thromboembolic disease prevention, surgical outcomes, and the evolution of minimally invasive techniques in urology. Loughlin's major contribution is his seminal 1995 review on the pathogenesis and prophylaxis of postoperative thromboembolic disease, which has garnered 55 citations and remains a foundational reference for clinicians seeking to reduce life-threatening blood clots after urological procedures. This work established evidence-based protocols that have shaped standard perioperative care. More recently, Loughlin has been a vocal advocate for the adoption of robot-assisted radical cystectomy, co-authoring a 2020 article arguing that this technology should "relentlessly make yourself obsolete" as it becomes the emerging standard of care for bladder cancer. His career reflects a commitment to both rigorous clinical research and forward-thinking surgical innovation, making him a respected voice in urology whose insights continue to guide safer, more effective patient outcomes.